| JYHB1801156 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2018-09-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-11-15 | view |
| JYHB1801155 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2018-09-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-11-15 | view |
| JYHB1801154 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2018-09-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-11-15 | view |
| JYHB1801153 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2018-09-20 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-11-15 | view |
| JYHB1701334 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2017-10-26 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2018-03-19 | view |
| JYHB1700867 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2017-06-19 | AbbVie Inc. | Abbvie Inc | Filed | 2017-09-12 | view |
| JYHB1700852 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2017-06-16 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-11-07 | view |
| JYHB1601611 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2016-12-06 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-05-12 | view |
| JYHB1501553 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-11-04 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2017-06-28 | view |
| JYHB1501395 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-09-28 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-25 | view |
| JYHB1500712 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-05-25 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-07-18 | view |
| JYHB1500411 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2015-04-10 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2016-05-31 | view |
| JYHB1400912 | 洛匹那韦/利托那韦口服液体 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2014-07-25 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2015-01-27 | view |
| JXSL2000219 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2020-12-09 | view |
| JXSL2000218 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2020-12-09 | view |
| JXSL1800067 | Risankizumab注射液（ABBV-066）300mg/3.33mL | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXSL1800066 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXSL1800065 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXSL1800064 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXSL1800063 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-08 | view |
